Skip to main content
. 2022 Sep 21;14(19):4575. doi: 10.3390/cancers14194575

Figure 3.

Figure 3

Flow cytometric analysis of conventional dendritic cell lineage I and II cells in melanoma (A,B) and lung cancer (C,D) demonstrated that response to therapy was tumor-dependent; in melanoma, there were significant differences among both populations based on treatment group whereas these differences were not observed in lung cancer (n = 3 per group). Significant differences are marked with a line with an asterisk. (Dendritic cells: CD3/CD19/CD11c+/MHCII+; conventional DC lineage I: CD3/CD19/CD11c+/MHCII+/XCR1+/CD11b–/low, conventional DC lineage II: CD3/CD19/CD11c+/MHCII+/XCR1/CD11b+).